Countries in the Mediterranean region—thought to have one of the healthiest diets in the world—now have the highest rates of childhood obesity in Europe, according to data presented last week.

A higher testosterone-to-estrogen ratio could be a harbinger of future cardiovascular disease (CVD) among post-menopausal women, according to a study published May 28 in the Journal of the American College of Cardiology.

Hypertensive patients collect $1,920 more in annual healthcare expenditures compared to healthy individuals, according to a study published in the Journal of the American Heart Association on May 30.

The debate over the ideal blood glucose target for type 2 diabetics continued this week in the Annals of Internal Medicine, with a group of researchers defending the current recommendations of below 7 percent.

Total adherence to the 2017 hypertension guidelines would result in about 330,000 fewer deaths each year in the U.S., according to a study published May 23 in JAMA Cardiology.

Two late-breaking clinical trials presented May 23 at EuroPCR in London demonstrated the ability of renal denervation to significantly lower patients’ blood pressures, regardless of whether they were taking antihypertensive medications.

Children who experienced partial readmission of new-onset type 1 diabetes had significantly lower total cholesterol levels and LDL cholesterol levels compared with non-remitters four to five years after diagnosis, according to a single-center study published May 16 in PLOS One.

PASADENA, Calif., May 16, 2018 — The FH Foundation, a leading research and advocacy organization, today announced the launch of a new research study that aims to understand the willingness for individuals with a clinical diagnosis of familial hypercholesterolemia (FH) and their family members to undergo confirmatory genetic testing, through a partnership with Color Genomics.